C2N Diagnostics - Crunchbase Company Profile & Funding

Q: Who invested in C2N Diagnostics?

C2N Diagnostics has 8 investors including Samsung C&T Corporation And Samsung Venture Investment.

Q: When was the last funding round for C2N Diagnostics?

C2N Diagnostics closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has C2N Diagnostics raised to date?

C2N Diagnostics has raised obfuscated.

Overview

C2N Diagnostics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+3 more milestones

See more interactive data and historical milestones on desktop for the best experience

About C2N Diagnostics

CB Rank

5708

C2N Diagnostics is a specialty company focused on brain health and neurodegenerative diagnostics, advancing early detection solutions.

Founded

obfuscation

Private

Venture - Series Unknown

Saint Louis, Missouri, United States

101-250

c2n.com

Biotechnology

Health Care

Health Diagnostics

Medical

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Corporate Round

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Ilana Fogelman: VP, Regulatory and Clinical Affairs
Joel B. Braunstein: CEO, Co-Founder and Board Member
Past Role: Tivorsan Pharmaceuticals, Co-Founder

Details

Legal Name

C2N Diagnostics

Operating Status

Active

Company Type

For Profit

Founders

David Holtzman, Joel B. Braunstein, Randall Bateman

About the Company

C2N Diagnostics is a specialty diagnostics company focused on providing laboratory services and products in brain health with innovative technologies. The C2N Diagnostics PrecivityAD Test helps physicians determine the presence of amyloid plaques in the brain, which is crucial for Alzheimer's diagnosis. C2N is known for its high-performance

blood biomarkers aimed at early diagnosis and therapeutic discovery related to brain health conditions.

Phone Number

314-633-1884

Contact Email

info@C2NDiagnostics.com

Predictions & Insights

Growth Insight

See this Growth Insight

C2N Diagnostics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

PrecivityAD2™/PrecivityAD®

Blood tests for patients aged 55 and older with cognitive impairment, aiding in the evaluation of Alzheimer’s disease or dementia by determining the presence of amyloid plaques in the brain.

Precivity-ApoE™

A blood test for adult patients, providing apolipoprotein E2,E3,E4 allele status information for medical management and treatment decisions.

Research & Development

C2N Diagnostics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - C2N Diagnostics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - C2N Diagnostics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - C2N Diagnostics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - C2N Diagnostics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - C2N Diagnostics	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - C2N Diagnostics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - C2N Diagnostics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - C2N Diagnostics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - C2N Diagnostics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - C2N Diagnostics	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Samsung C&T Corporation	—	Corporate Round - C2N Diagnostics	—
Samsung C&T Corporation	—	Corporate Round - C2N Diagnostics	—
Samsung C&T Corporation	—	Corporate Round - C2N Diagnostics	—
Samsung C&T Corporation	—	Corporate Round - C2N Diagnostics	—
Samsung C&T Corporation	—	Corporate Round - C2N Diagnostics	—